Skip to main content
Clinical Trials/NL-OMON26856
NL-OMON26856
Recruiting
Not Applicable

Improving emotion recognition in children with Autism Spectrum Disorders and Borderline Intellectual Functioning: A Randomized Double-blind Placebo-controlled Intervention Study

Karakter Child- and Adolescent Psychiatry0 sites44 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
* Autism spectrum disorder* ASD* Autism* PDD-NOS* Borderline intellectual functioning* Intellectual disability
Sponsor
Karakter Child- and Adolescent Psychiatry
Enrollment
44
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

ot applicable

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Karakter Child- and Adolescent Psychiatry

Eligibility Criteria

Inclusion Criteria

  • \* Children aged between 6 years, 0 months and 9 years, 11 months \- known in psychiatric health care
  • \* Children with an Autism Spectrum Disorder, classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM\-IV).
  • \* IQ scores between 70 and 85 ('borderline intellectual functioning')
  • \* Access to a PC or TIV with DVD\-player
  • \* A comorbid ADHD diagnosis is allowed, as long as it is sufficiently treated with medication and dosage is stabile during the intervention.

Exclusion Criteria

  • \* Currenlty intensive (ie weekly) individual or group therapy
  • \* Diagnosis of one or more of the following comorbid psychiatric disorders:
  • \- major depression
  • \- psychotic disorder
  • \- conduct disorder
  • \- attachment disorder
  • \- serious moto and/or perceptual disability
  • \* Simultaneous participation in another clinical trial
  • \* Insufficient motivation for the completing the treatment
  • \* Medical illness that needs treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials